Core Viewpoint - Dajia Weikang has decided to terminate its plan for a private placement of shares and withdraw the application due to the current capital market environment and after thorough communication and analysis among relevant parties [1][4]. Group 1: Termination of Share Issuance - The company held meetings on April 3 to approve the termination of the private placement of shares and the withdrawal of the application [1]. - The planned issuance was intended to raise up to 120 million yuan, with a share price of 7.45 yuan per share, and a maximum of 16,107,382 shares to be issued [1]. - The funds were to be used to supplement working capital after deducting issuance costs [1]. Group 2: Shareholder Information - The intended recipient of the shares was Wang Yiqing, a controlling shareholder and chairman of the company, who was to sign a conditional share subscription agreement [2]. - Wang Yiqing directly holds 70,144,219 shares and indirectly controls an additional 9,800,000 shares, totaling 79,944,219 shares, which is 38.92% of the company's total equity [2]. - Together with his spouse, they control 39.60% of the voting rights in the company [2]. Group 3: Previous Fundraising Efforts - Dajia Weikang was listed on the Shenzhen Stock Exchange on December 7, 2021, raising 639 million yuan, with a net amount of 569 million yuan after expenses [3]. - The funds from the initial public offering were intended for chain pharmacy expansion, smart logistics center projects, and repaying bank loans [3]. - The company had previously announced the termination of a simplified procedure for a private placement in 2022, which aimed to raise up to 199.12 million yuan for acquisitions and working capital [5].
达嘉维康终止向实控人不超1.2亿定增 2021上市募6.4亿